Renyi Qin

Chinese PLA General Hospital

Papers

1

Total Citations

30

H-Index

1

About

Renyi Qin is a leading figure in pancreatic surgery, with a focused expertise in minimally invasive approaches for pancreatic cancer. His major contributions center on rigorously comparing surgical outcomes through high-level evidence synthesis. In his landmark 2023 individual patient data meta-analysis of randomized trials, Qin demonstrated that minimally invasive pancreatoduodenectomy offers comparable oncologic outcomes to open surgery for pancreatic ductal adenocarcinoma, while potentially reducing recovery times. This work, which has already garnered 30 citations, has helped clarify long-standing debates about the safety and efficacy of laparoscopic and robotic techniques in complex pancreatic resections. Beyond this pivotal study, Qin’s research portfolio spans surgical innovation, perioperative management, and long-term survival analysis for pancreatic malignancies. His work is widely cited by surgeons and oncologists seeking evidence-based guidance for treatment selection. By systematically evaluating the trade-offs between surgical approaches, Qin has directly influenced clinical decision-making and helped shape modern standards of care for one of the most challenging cancers to treat.

Research Focus

Key Achievements

1
H-Index
1
Papers
30
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: Individual patient data meta-analysis of randomized trials
30 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Chinese PLA General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago